Tumor Hypoxia and Malignant Progression
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Solid malignant tumors commonly contain hypoxic areas, and direct measurement of tissue oxygenation using O 2 -sensitive microsensors has shown that the tumor microenvironment is characterized by much lower P O2 values than their normal counterparts (Vaupel et al., 2004).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Vaupel et al., 2004
In the citing paper
“The severe intratumoral hypoxia detected in these studies is a result of diffusion-limited O2 delivery, in which rapid cancer cell proliferation leads to cells that are too far away from a blood vessel, and perfusion-limited O2 delivery, in which structurally and functionally abnormal tumor vessels do not maintain constant blood flow, so that cancer cells even immediately adjacent to a blood vess”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [8]
Citations
Cites
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
(1989) · PubMed · Cited by 3,343
Self-citationAP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Self-citationRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,926
Self-citationHolmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
(1991) · PubMed · Cited by 1,305
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213
(1996) · PubMed · Cited by 1,188
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
(2002) · PubMed · Cited by 840
Sowter, H., Ratcliffe, P. J., Watson, P. H., Greenberg, A. H., & Harris, A. L. (2001) · PubMed · Cited by 828
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 801
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 654
(2003) · PubMed · Cited by 624
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
Self-citationKoong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 525
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Tomlinson, I. P. M., Novelli, M. R., & Bodmer, W. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14800 · Cited by 458
Coquelle, A., Pipiras, E., Toledo, F., Buttin, G., & Debatisse, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80201-9 · Cited by 391
Hypoxic cervical cancers with low apoptotic index are highly aggressive.
Höckel, M., Schlenger, K., Höckel, S., & Vaupel, P. W. (1999) · PubMed · Cited by 388
Self-citationHypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
Young, S. D., Marshall, R. S., & Hill, R. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9533 · Cited by 381
Transcriptional Response to Hypoxia in Human Tumors
Lal, A., Peters, H., St. Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., & Riggins, G. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1337 · Cited by 320
Stone, H. B., Brown, J. M., Phillips, T. L., & Sutherland, R. M. (1993) · Radiation Research · doi:10.2307/3578556 · Cited by 303
(2001) · PubMed · Cited by 292
Kietzmann, T., Roth, U., & Jungermann, K. (1999) · Blood · doi:10.1182/blood.v94.12.4177 · Cited by 256
Rice, G. C., Hoy, C., & Schimke, R. T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5978 · Cited by 249
Teicher, B. A., Holden, S. A., Al-Achi, A., & Herman, T. S. (1990) · PubMed · Cited by 225
DAMERT, A., IKEDA, E., & RISAU, W. (1997) · Biochemical Journal · doi:10.1042/bj3270419 · Cited by 216
A New Role for Hypoxia in Tumor Progression
Coquelle, A., Toledo, F., Stern, S., Bieth, A., & Debatisse, M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80137-9 · Cited by 215
Hypoxia in Breast Cancer: Pathogenesis, Characterization and Biological/Therapeutic Implications
Vaupel, P., Briest, S., & Hockel, M. (2002) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2002.02032.x · Cited by 209
Self-citationInvolvement of Hypoxia-Inducible Factor 1 in Human Cancer.
SEMENZA, G. L. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.79 · Cited by 208
(2000) · PubMed · Cited by 207
Pugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
Oxymetry deep in tissues with low-frequency electron paramagnetic resonance.
Halpern, H. J., Yu, C., Peric, M., Barth, E., Grdina, D. J., & Teicher, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13047 · Cited by 195
Graham, C. H., Forsdike, J., Fitzgerald, C. J., & Macdonald-Goodfellow, S. K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4<595::aid-ijc18>3.0.co;2-b · Cited by 195
Graham, C. H., Forsdike, J., Fitzgerald, C. J., & Macdonald-Goodfellow, S. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4<617::aid-ijc22>3.0.co;2-c · Cited by 192
Baek, J. H., Jang, J.-E., Kang, C.-M., Chung, H.-Y., Kim, N. D., & Kim, K.-W. (2000) · Oncogene · doi:10.1038/sj.onc.1203814 · Cited by 189
Sundfør, K., Lyng, H., & Rofstad, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.586 · Cited by 186
Fan, C., Li, Q., Ross, D., & Engelhardt, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206718200 · Cited by 183
Rupec, R. A., & Baeuerle, P. A. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.632_b.x · Cited by 180
Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy
Democheli, R., Tereziani, M., Valagussa, P., Moliterni, A., Zambetti, M., & Bonadonna, G. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.1.45 · Cited by 176
DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation
Swanson, H. I. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00066-2 · Cited by 176
Kondo, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.769 · Cited by 172
The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy
Mazurek, S., Boschek, C. B., & EIGENBRODT, E. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022490512705 · Cited by 172
Cuvier, C., Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018428105463 · Cited by 169
Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour
Tanaka, S., Akaike, T., Fang, J., Beppu, T., Ogawa, M., Tamura, F., Miyamoto, Y., & Maeda, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600830 · Cited by 166
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
Chapman, J. D., Engelhardt, E. L., Stobbe, C. C., Schneider, R. F., & Hanks, G. E. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00186-2 · Cited by 164
Tumor hypoxia in pelvic recurrences of cervical cancer
Höckel, M., Schlenger, K., Höckel, S., Aral, B., Schäffer, U., & Vaupel, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<365::aid-ijc10>3.0.co;2-4 · Cited by 162
Self-citationHypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 154
A Factor of Importance in the Radio Sensitivity of Tumours
Mottram, J. C. (1936) · The British Journal of Radiology · doi:10.1259/0007-1285-9-105-606 · Cited by 146
Kim, C., Tsai, M. H., Osmanian, C., Graeber, T. G., Lee, J. E., Giffard, R. G., DiPaolo, J. A., Peehl, D. M., & Giaccia, A. J. (1997) · PubMed · Cited by 143
Chromosome 18q allelic loss and prognosis in stage II and III colon cancer
Lanza, G., Matteuzzi, M., Gafá, R., Orvieto, E., Maestri, I., Santini, A., & del Senno, L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<390::aid-ijc14>3.0.co;2-9 · Cited by 141
Self-citationThe inhibition of tumor growth by tumor mass.
Prehn, R. T. (1991) · PubMed · Cited by 138
Chapman, J. D. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90181-f · Cited by 134
Intracapillary oxyhemoglobin saturation of malignant tumors in humans
Mueller‐Klieser, W., Vaupel, P. W., Manz, R., & Schmidseder, R. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90036-5 · Cited by 130
Self-citationOxygen Regulation of Gene Expression: A Study in Opposites
D'Angio, C. T., & Finkelstein, J. N. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3074 · Cited by 124
Tamatani, M., Mitsuda, N., Matsuzaki, H., Okado, H., Miyake, S., Vitek, M. P., Yamaguchi, A., & Tohyama, M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750683.x · Cited by 116
Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells
Li, G., Tian, Y., & Yan, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02707-9 · Cited by 105
The response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent
Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G.-C., Mendonca, H. L., Ryan, H. E., Wang, Z., & Johnson, R. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2515-2523.2002 · Cited by 105
Microtubule Disruption Utilizes an NFκB-dependent Pathway to Stabilize HIF-1α Protein
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209804200 · Cited by 99
Microsatellite Instability in Human Cancer: A Prognostic Marker for Chemotherapy?
Claij, N., & Riele, H. T. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4299 · Cited by 91
Niizeki, H., Kobayashi, M., Horiuchi, I., Akakura, N., Chen, J., Wang, J., Hamada, J.-I., Seth, P., Katoh, H., Watanabe, H., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600331 · Cited by 89
Collingridge, D. R., Young, W. K., Vojnovic, B., Wardman, P., Lynch, E. M., Hill, S. A., & Chaplin, D. J. (1997) · Radiation Research · doi:10.2307/3579340 · Cited by 87
Russo, C. A., Weber, T. K., Volpe, C. M., Stoler, D. L., Petrelli, N. J., Rodríguez-Bigas, M. A., Burhans, W. C., & Anderson, G. R. (1995) · PubMed · Cited by 80
A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
Acker, T., & Plate, K. H. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0355-1 · Cited by 78
Measuring Hypoxia in Solid Tumours&Is There a Gold Standard?
Olive, P. L. (2001) · Acta Oncologica · doi:10.1080/02841860152708189 · Cited by 74
Dai, S., Huang, M. L., Hsu, C. Y., & Chao, K. S. C. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04507-8 · Cited by 63
Stoler, D. L., Anderson, G. R., Russo, C. A., Spina, A., & Beerman, T. A. (1992) · PubMed · Cited by 54
Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm?
Coleman, C. N., Mitchell, J. B., & Camphausen, K. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.610 · Cited by 51
The Effect of Hypoxia on the Generation Time of Mammalian Cells
Koch, C. J., Kruuv, J., & Frey, H. E. (1973) · Radiation Research · doi:10.2307/3573446 · Cited by 49
Cellular physiology and molecular events in hypoxia-induced apoptosis.
Riva, C., Chauvin, C., Pison, C. M., & Leverve, X. M. (1998) · PubMed · Cited by 49
Effects of anthracyclines on oxygenated and hypoxic tumor cells.
Kennedy, K. A., Siegfried, J. M., Sartorelli, A. C., & Tritton, T. R. (1983) · PubMed · Cited by 48
Åmellem, Ø., Löffler, M., & Pettersen, E. O. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.411 · Cited by 44
Tumor hypoxia is important in radiotherapy, but how should we measure it?
Brown, J. M., & Le, Q. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03936-6 · Cited by 36
Measurements of pO2 in Vivo, Including Human Subjects, by Electron Paramagnetic Resonance
Swartz, H. M., Bačić, G., Friedman, B. J., Goda, F., Grinberg, O. Y., Hoopes, P. J., Jiang, J., Liu, K. J., Nakashima, T., O’Hara, J. A., et al. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1875-4_16 · Cited by 32
Relevant parameters for describing the oxygenation status of solid tumors.
Thews, O., & Vaupel, P. W. (1996) · PubMed · Cited by 30
Self-citationChiarugi, V. P., Magnelli, L., Chiarugi, A., & Gallo, O. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050312 · Cited by 29
Nowrousian, M. R. (2008) · Springer eBooks · doi:10.1007/978-3-211-69459-6 · Cited by 22
Evidence for and Against Hypoxia as the Primary Cause of Tumor Aggressiveness
Okunieff, P. G., Ding, I., Vaupel, P. W., & Höckel, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0205-0_12 · Cited by 15
Self-citation(2002) · Springer eBooks · doi:10.1007/978-3-7091-7658-0 · Cited by 13
Yamagata, M., Kanematsu, T., Matsumata, T., Utsunomiya, T., Ikeda, Y., & Sugimachi, K. (1992) · PubMed · Cited by 10
Research works printed but not linked: 24
- Riva, 1998, Anticancer Res., 18, 4729
- Sowter, 2001, Cancer Res., 61, 6669
- Prehn, 1991, Cancer Res., 51, 2
- Höckel, 1996, Cancer Res., 56, 4509
- Brizel, 1996, Cancer Res., 56, 941
- Höckel, 1999, Cancer Res., 59, 4525
- Vaupel, 1989, Cancer Res., 49, 6449
- Thews, 1996, Strahlenther. Onkol., 172, 239
- Harris, 2002, Nature, 2, 38
- Feldser, 1999, Cancer Res., 59, 3915
- Krishnamachary, 2003, Cancer Res., 63, 1138
- Koong, 1994, Cancer Res., 54, 1425
- Loeb, 1991, Cancer Res., 51, 3075
- Yuan, 2000, Cancer Res., 60, 4372
- Stoler, 1992, Cancer Res., 52, 4372
- Russo, 1995, Cancer Res., 55, 1122
- Cairns, 2001, Cancer Res., 61, 8903
- Rofstad, 1996, Br. J. Cancer, 27, S136
- Kim, 1997, Cancer Res., 57, 4200
- Teicher, 1990, Cancer Res., 50, 3339
- Yamagata, 1992, Eur. J. Surg. Oncol., 18, 379
- Kennedy, 1983, Cancer Res., 43, 54
- Comerford, 2002, Cancer Res., 62, 3387
- Loncaster, 2001, Cancer Res., 61, 6394
Cited by
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
“The mean PO2 is 10 mm Hg in breast cancer as compared to >60 mm Hg in normal breast tissue, and cancers with PO2 < 10 mm Hg are associated with increased risk of metastasis and patient mortality (Vaupel et al., 2004).”
BackgroundHypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
“Tumor hypoxia is classically associated with resistance to radiotherapy, but has also been shown to diminish the efficacy of certain forms of chemotherapy, of photodynamic therapy and immunotherapy (for reviews see [1, 3, 6, 21]).”
BackgroundSelf-citationDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
“For example, the median PO2 level measured in breast cancers was 10mmHg, as compared to 65mmHg in normal breast tissue (Vaupel et al., 2004).”
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
“Genetic and metabolic activators of HIF-1 Hypoxia plays a crucial role in cancer progression [2,5] but not all cancer cells are hypoxic and a growing number of O2-independent mechanisms have been identified by which HIF-1 is induced [5].”
Metadata
- Authors
- Vaupel, P., Mayer, A., & Höckel, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Venue
- Methods in Enzymology
- Publisher
- Elsevier
- Published
- 2004
- Volume
- 381
- Pages
- 335-354
- ISSN
- 0076-6879 (ISSN-L)
- OpenAlex
- W1547961512
- Cited by
- 496
- References
- 88
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 21 · 2023: 25 · 2022: 39 · 2021: 38 · 2020: 30 · 2019: 26 · 2018: 32 · 2017: 30 · 2016: 23 · 2015: 22 · 2014: 28 · 2013: 19 · 2012: 28
- FWCI
- 23.91
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Methods in enzymology on CD-ROM/Methods in enzymology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, malignant progression, solid tumors, tumor microvasculature, oxygen consumption, oxygen diffusion, tumor stroma
- MeSH terms
- Hypoxia, Electron Spin Resonance Spectroscopy, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Neoplasm Invasiveness, Neoplasms, Magnetic Resonance Spectroscopy, Oxygen, Prognosis, Transcription Factors, Drug Resistance, Neoplasm, Genomic Instability, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.